ALK and colorectal carcinoma: Importantly, ALK expression has been negatively correlated with relapse-free survival (RFS) in consensus molecular subtype 1 (CMS1) colorectal carcinoma compared to CMS1 tumors without ALK expression (hazard ratio of 2.77)6.